Definitive Contract 36C24422C0017

Quest Diagnostics Incorporated will provide laboratory testing and analysis services to the National Cancer Institute (NCI), an institute of the National Institutes of Health within the Department of Health and Human Services, under a $1.1 million time-and-materials delivery order awarded against the Medical Laboratory Testing and Analysis Services Federal Supply Schedule. Specifically, Quest Diagnostics will perform coagulopathy biomarker assays and send the results to NCI to support analyses...

The Department of Veterans Affairs (VA) awarded a $129,475.00 contract to Color Health Inc. for hereditary cancer test kits, testing, and counseling services for the VA Puget Sound Healthcare System Research & Development. The contract is a firm-fixed-price purchase order with a one-year base period and one-year option. The original solicitation was issued as a commercial services contract under FAR Part 12 and 13, with a North American Industry Classification System (NAICS) code of 621511...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,059 purchase order to the College of American Pathologists, doing business as C.a.p., for proficiency testing kits. The firm fixed price contract runs from January 1, 2024 through December 31, 2024 and will be performed in Winnetka, Illinois. No additional details were provided regarding subcontractors or the scope of the testing kits. The National Cancer Institute supports...

<p>The National Cancer Institute, a civilian federal agency, awarded a firm-fixed-price purchase order contract worth $14,500.00 to Labcorp Genetics Inc. for genetic testing services. The contract has an ultimate completion date of October 31, 2025 and was awarded on April 30, 2025. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,696 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. of Newark, California for lab testing services. As the prime contractor, Advanced Cell Diagnostics will provide the requested testing services to the agency. Advanced Cell Diagnostics is a subsidiary of Bio-Techne Corporation, located in Newark. The award does not have a set-aside designation. The contract has a...

This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to the Cancer Prevention Institute of California, a non-profit organization, to conduct a &quot;Patterns of Care/Quality of Care Study: Diagnosis Year 2016&quot; from July 31, 2017 to July 30, 2018. The contract, which has a firm fixed price of $159,811.00, is a delivery order that is not set aside for any particular business type. The study is part of the Surveillance, Epidemiology and End Results...

This is a firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Natera Inc., a biotechnology company specializing in advanced genetic and molecular diagnostic testing services. The contract, valued at $328,300.00, is for tumor whole exome sequencing (WES) and peripheral blood circulating tumor DNA (ctDNA) testing services to support a VA-funded research study on 98 esophageal cancer patients. The contract has a one-year base period with four one-year option periods, and...

This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Polymedco Cancer Diagnostic Products LLC, a small disadvantaged business, for the provision of &quot;AUTO BLOOD TESTS&quot;. The contract, which is a Blanket Purchase Agreement (BPA) call against a Critical Analyzers, Laboratory master schedule, has a ceiling value of $64,038.91 and was awarded on October 10, 2012 with an ultimate completion date of October 9, 2017. The contract is for firm-fixed-price supplies...

The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 22 (VISN 22), awarded a firm-fixed-price purchase order to Myriad Genetics Inc. for $154,938.00 to provide Prolaris genetic testing services. Prolaris is a molecular diagnostic test that measures gene expression levels to assess prostate cancer aggressiveness. This contract is for the VA Long Beach Healthcare System to utilize Myriad's Prolaris testing capabilities on an as-needed basis from...

The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $24,500 purchase order to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. for laboratory testing services. The firm fixed price contract runs from September 1, 2023 through February 29, 2024 and will be performed in Boulder, Colorado. No additional details were provided regarding the scope of laboratory testing services requested under the...